发明公开
- 专利标题： QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS
- 专利标题（中）： 喹唑啉酮作为CRTH2拮抗剂
-
申请号： EP11833150.3申请日： 2011-10-06
-
公开(公告)号： EP2627178A1公开(公告)日： 2013-08-21
- 发明人: PALANI, Anandan , ASLANIAN, Robert, G. , BOYCE, Christopher, W. , MAZZOLA, Robert, D.,Jr. , MCKITTRICK, Brian, A. , MCCORMICK, Kevin, D. , QIN, Jun , TANG, Haiqun , XIAO, Dong , YU, Younong , CALDWELL, John, P. , KELLEY, Elizabeth, Helen , ZHANG, Hongjun , SILIPHAIVANH, Phieng , MACCOSS, Rachel, N. , METHOT, Joey, L. , GAUUAN, Jolicia, Polivina , JIANG, Qin , LEYHANE, Andrew, J. , BIJU, Purakkattle Johny , DONG, Li , HUANG, Xianhai , SHAO, Ning , ZHOU, Wei , DHONDI, Pawan, K. , RAO, Ashwin, U.
- 申请人： Merck Sharp & Dohme Corp.
- 申请人地址： 126 East Lincoln Avenue Rahway, NJ 07065-0907 US
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： 126 East Lincoln Avenue Rahway, NJ 07065-0907 US
- 代理机构： Horgan, James Michael Frederic
- 优先权： US391864P 20101011
- 国际公布： WO2012051036 20120419
- 主分类号： A01N43/54
- IPC分类号： A01N43/54 ; C07D239/42 ; C07D401/04
摘要：
This application provides for compounds of the formula Formula I or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTH
2 receptor.
2 receptor.
公开/授权文献
- EP2627178B1 QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS 公开/授权日：2018-05-02
信息查询
IPC分类:
